机构:[1]Department of Urology Surgery, Fuxing Hospital Affiliated to Capital Medical University, Xicheng District, Beijing, China.[2]Department of Urology Surgery, The Fourth Hospital of Hebei Medical University, Hebei, PR China.临床科室泌尿外科河北医科大学第四医院
第一作者机构:[1]Department of Urology Surgery, Fuxing Hospital Affiliated to Capital Medical University, Xicheng District, Beijing, China.[*1]Department of Urology Surgery, Fuxing Hospital Affiliated to Capital Medical University, No. 20 Fuxingmenwai Dajie, Xicheng District, Beijing 100038, China
通讯作者:
通讯机构:[1]Department of Urology Surgery, Fuxing Hospital Affiliated to Capital Medical University, Xicheng District, Beijing, China.[*1]Department of Urology Surgery, Fuxing Hospital Affiliated to Capital Medical University, No. 20 Fuxingmenwai Dajie, Xicheng District, Beijing 100038, China
推荐引用方式(GB/T 7714):
Zhang Lei,Liu Bin,Su Jianzhi.CCNB2 as a potential biomarker of bladder cancer via the high throughput technology[J].MEDICINE.2023,102(6):doi:10.1097/MD.0000000000032825.
APA:
Zhang Lei,Liu Bin&Su Jianzhi.(2023).CCNB2 as a potential biomarker of bladder cancer via the high throughput technology.MEDICINE,102,(6)
MLA:
Zhang Lei,et al."CCNB2 as a potential biomarker of bladder cancer via the high throughput technology".MEDICINE 102..6(2023)